BrotherlyACT: A Culturally Congruent and Technology-Enhanced Youth Violence and Substance Use Intervention for Black Boys and Men
Conditions: Violence in Adolescence; Substance Use; Avoidance of Healthcare Interventions: Behavioral: BrotherlyACT; Other: BrotherlyACT Waitlist Control Group (WCG) Sponsors: Rush University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Relationship of Lifestyle Habits and Health Characteristics of Parents and Children
Conditions: Adult Fathers and Mothers; Children and Adolescents, Boys and Girls Interventions: Other: No intervention Sponsors: Universidade Estadual Paulista J úlio de Mesquita Filho Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Development and Testing of a Sports Intervention to Promote Physical Activity in Rural Girls
Conditions: Healthy Interventions: Behavioral: Girls PLAY program Sponsors: San Diego State University; Boys and Girls Clubs of Imperial Valley; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Cryopreservation of Prepubertal Testicular Tissue for Preservation of Fertility in Young Boys With Cancer
Conditions: Fertility Disorders; Childhood Cancer Interventions: Procedure: Testicular Biopsy Sponsors: University of Edinburgh; University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
A Phase 1/2 of NS-050/NCNP-03 in Boys With DMD (Meteor50)
Condition: Duchenne Muscular Dystrophy Interventions: Drug: NS-050/NCNP-03; Drug: Placebo Sponsors: NS Pharma, Inc.; Nippon Shinyaku Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
A Phase 1/2 of NS-050/NCNP-03 in Boys With DMD (Meteor50)
Conditions: Duchenne Muscular Dystrophy Interventions: Drug: NS-050/NCNP-03; Drug: Placebo Sponsors: NS Pharma, Inc.; Nippon Shinyaku Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy Intervention: Drug: NS-089/NCNP-02 Sponsor: NS Pharma, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
